Vitor Rodrigues da Costa

Vitor Rodrigues da Costa

Auto-generated profile, based on publicly available information

Vitor Rodrigues da Costa

Programa de Pós-Graduação em Biologia Estrutural e Funcional, Escola Paulista de Medicina da Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo-SP 04039-032, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Endocrine Pathology
Verified
Journal Article
Closed access
PDF file
MSMaria José Carregosa Pinheiro dos Santos
Maria José Carregosa Pinheiro dos Santos
ABAndré Uchimura Bastos
André Uchimura Bastos
VCVitor Rodrigues da Costa
Vitor Rodrigues da Costa
RDRosana Delcelo
Rosana Delcelo
SLSusan Chow Lindsey
Susan Chow Lindsey
JCJanete Cerutti
Janete Cerutti

29 June 2023
Verified
Journal Article
Open access
PDF file
MTMichelli Ramires Teixeira
Michelli Ramires Teixeira
AAAnderson Lucas Alievi
Anderson Lucas Alievi
VCVitor Rodrigues da Costa
Vitor Rodrigues da Costa
JPJoão Rafael Dias Pinto
João Rafael Dias Pinto
RARodrigo Araldi
Rodrigo Araldi
Globally, the incidence of Parkinson’s disease (PD) is increasing faster than other neurodegenerative disorders. Neuropathologically, PD is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta due to the accumulation of aggregates of misfolded α-synuclein (α-Syn) in the cytoplasm of these neurons, forming Lewy bodies. Extracellular vesicles (EVs) are associated with the spread of α-Syn to different brain areas. However, at the same time that these EVs contribute to the pathophysiology of PD, they can also be explored as therapeutic, serving as a vehicle to deliver specific molecules, since these vesicles can easily cross the blood-brain barrier. Thus, this review summarizes the recent progress in EVs as a therapeutic strategy for PD, focusing on their delivery to the brain, and discusses the potential challenges and future directions in this field.

14 March 2023 in Exploration of Immunology
Verified
Journal Article
Open access
PDF file
VCVitor Rodrigues da Costa
Vitor Rodrigues da Costa
OSOlivia Souza
Olivia Souza
MTMichelli Ramires Teixeira
Michelli Ramires Teixeira
AAAnderson Lucas Alievi
Anderson Lucas Alievi
HVHugo Vigerelli
Hugo Vigerelli
RARodrigo Araldi
Rodrigo Araldi
Lung cancer is the leading cause of cancer-related deaths worldwide. The main risk factor for lung cancer is exposure to chemicals present in cigarettes and atmospheric pollutants, which, among othe